Form 4: ALUMIS Director Akkaraju Boosts Stake via Fund

ALUMIS Director Srinivas Akkaraju reports an indirect purchase of 276,179 common shares through Samsara Opportunity Fund.

Summary

• Srinivas Akkaraju, a Director of ALUMIS INC. (ALMS), reported a change in beneficial ownership.
• The transaction involved the indirect acquisition of 276,179 shares of Common Stock.
• The shares were purchased at a price of $5.25 per share.
• The transaction occurred on November 13, 2025.
• The shares were acquired by Samsara Opportunity Fund, L.P., an entity over which Akkaraju has voting and investment power.
• This purchase was part of a privately negotiated transaction from Samsara BioCapital, L.P.
• Following this transaction, Samsara Opportunity Fund, L.P. beneficially owns 276,179 shares.
• Samsara BioCapital, L.P. now beneficially owns 4,491,731 shares after disposing of 276,179 shares to Samsara Opportunity Fund.
• Akkaraju disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.

Sentiment

Score: 7

Explanation: The filing indicates an insider purchase, which is generally viewed positively as it suggests confidence from a company director in the stock's future performance. However, it's a single transaction and doesn't provide broader financial or operational details.

Positives

• An insider (Director Srinivas Akkaraju) increased his indirect beneficial ownership in ALUMIS INC. by purchasing 276,179 shares.
• Insider buying can signal confidence in the company's future prospects from a key management figure.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The transaction involved a privately negotiated purchase of shares from Samsara BioCapital, L.P. by Samsara Opportunity Fund, L.P.
• Srinivas Akkaraju is a managing member of Samsara BioCapital GP, LLC (the general partner of Samsara LP) and also has voting and investment power over shares held by Samsara Opportunity Fund, L.P., indicating a transaction between entities where the reporting person has significant influence or control.

Stakeholder Impact

• Shareholders: May view the insider purchase as a positive signal of management confidence, potentially influencing investor sentiment.
• Employees, Customers, Suppliers, Creditors: Unlikely to be directly impacted by this specific insider transaction report.

Key Dates

Recommendation

While insider buying by a director is a positive signal, this Form 4 filing alone does not provide sufficient information on the company's fundamentals, financial performance, or strategic outlook to warrant a 'buy' or 'strong buy' recommendation. It suggests confidence from a key insider, which supports holding the stock, but further analysis of the company's broader financial health and market position is required for a stronger recommendation.

Keywords

ALUMIS INC., ALMS, Srinivas Akkaraju, Insider Trading, Form 4, Beneficial Ownership, Common Stock, Samsara Opportunity Fund, Samsara BioCapital, Director Purchase